Generali Investments Management Co LLC Has $387,000 Stock Holdings in CME Group Inc. $CME

Generali Investments Management Co LLC decreased its holdings in CME Group Inc. (NASDAQ:CME) by 55.1% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,752 shares of the financial services provider’s stock after selling 2,148 shares during the period. Generali Investments Management Co LLC’s holdings in CME Group were worth $387,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Asset Dedication LLC grew its position in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares during the last quarter. Whipplewood Advisors LLC raised its stake in CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 83 shares in the last quarter. Elkhorn Partners Limited Partnership bought a new position in shares of CME Group in the fourth quarter worth about $27,000. Hilton Head Capital Partners LLC bought a new position in shares of CME Group in the fourth quarter worth about $28,000. Finally, Legacy Wealth Managment LLC ID boosted its stake in shares of CME Group by 191.9% in the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 71 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. UBS Group decreased their price target on shares of CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a report on Monday, July 6th. Wall Street Zen lowered shares of CME Group from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 1st. Bank of America boosted their target price on shares of CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research note on Thursday, July 23rd. Erste Group Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Finally, Weiss Ratings downgraded shares of CME Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, July 13th. Eleven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $291.81.

CME Group Trading Down 0.0%

Shares of NASDAQ CME opened at $263.65 on Tuesday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16. The firm has a 50 day moving average price of $249.36 and a two-hundred day moving average price of $280.67. The stock has a market cap of $94.80 billion, a P/E ratio of 22.36, a price-to-earnings-growth ratio of 3.07 and a beta of 0.23.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The company had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the business earned $2.96 earnings per share. CME Group’s revenue was up .8% compared to the same quarter last year. As a group, equities analysts forecast that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

Insider Buying and Selling

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. The trade was a 17.20% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares in the company, valued at $16,606,111.30. This trade represents a 38.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by corporate insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.